WHEN NANO COMES TO LIFE
WHEN NANO COMES TO LIFE
WHEN NANO COMES TO LIFE

WE RETHINK THERAPY

With tailor-made nanocarriers, we will set new standards for the targeted, efficient and low-risk use of active pharmaceutical ingredients and other highly potent substances for medical and life science applications.

OUR VISION

We save human lives

by targeted use of highly potent substances

We rethink therapy

via tailor-made nanocarriers for efficiency and safety

We treat the untreatable

e.g. septic liver failure

NEWS

6th June 2025

SMARTDYELIVERY AT THE INVESTOR DAYS THURINGIA: ANNIVERSARY IN A HISTORIC ATMOSPHERE

On June 4 and 5 in Erfurt, young companies met with investors for the 10th time. The prelude with 10 innovative “scale-ups” presenting, took place at the Horticultural Museum in Egapark, providing a special setting for the topic of “growth”. The event continued in St. Peter's Church, which was bathed in a festive light for the 34 start-ups introducing themselves there. ...

22nd May 2025

WITH TEAM SPIRIT TO THE FINISH

The 14th Jena Corporate Run (Jenaer Firmenlauf) took place yesterday. SmartDyeLivery participated in this event for the first time. In perfect conditions and in high spirits, the team completed the approx. 5 km course in the Ernst-Abbe-Sportfeld together. It was a superbly organized event with a total of 3,500 starters. Part of the proceeds went to social projects in Jena.

2nd April 2025

CLINICAL PHASE I STUDY WITH POLYMERIC NANOPARTICLES STARTED

SmartDyeLivery’s Nanocarrier SDL-M1 was administered to humans for the first time. In the Phase I study, the safety and tolerability of the intravenously administered nanocarriers are being tested in healthy volunteers. SDL-M1 is the first application from SmartDyeLivery's technology platform and is designed to deliver an active substance specifically into the metabolic cells of the liver.

105

Patents Granted

EP, US, JP, CN, CA …

108

Pending Applications

EP, US, JP, CN, CA …

1

Utility Model

∞

Countless Company Secrets